Bumi Armada Bhd (ARMADA):企業の財務・戦略的SWOT分析

◆英語タイトル:Bumi Armada Bhd (ARMADA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0552
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bumi Armada Bhd (ARMADA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bumi Armada Bhd (Bumi Armada) is a provider of integrated offshore solutions. The company owns and operates Floating Production Storage and Offloading (FPSO), Offshore Support Vessels (OSV), pipelaying barges, and subsea vessels. Its FPSO portfolio includes Armada TGT 1, Armada Sterling, Armada Sterling II and Armada Perdana. The company’s OSVs includes including anchor handling tug support (AHTS) vessels, accommodation workbarges / workboats, platform support vessels (PSVs), mooring launches, utility vessels and oil terminal support vessels. It offers conventional installation, floater installation and subsea umbilicals, risers and flowline installation services. The company has operational presence in Asia-Pacific, Europe, Africa and Latin America. Bumi Armada is headquartered in Kuala Lumpur, Malaysia.

Bumi Armada Bhd Key Recent Developments

Nov 22,2019: Bumi Armada reports net profit of RM153 million boosted by one off gains in third quarter of 2019
Oct 16,2019: Bumi Armada announces change of address
Oct 11,2019: Armada Floating Gas Storage Malta enters into 6-year term loan facility of USD45 million from Mezzanine Equities
Aug 30,2019: Bumi Armada announces quarterly report on consolidated results for financial period ended 30/06/2019
May 27,2019: Bumi Armada announces quarterly rpt on consolidated results for financial period ended 31 Mar 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bumi Armada Bhd – Key Facts
Bumi Armada Bhd – Key Employees
Bumi Armada Bhd – Key Employee Biographies
Bumi Armada Bhd – Major Products and Services
Bumi Armada Bhd – History
Bumi Armada Bhd – Company Statement
Bumi Armada Bhd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Bumi Armada Bhd – Business Description
Business Segment: FPO
Overview
Performance
Key Stats
Business Segment: OMS
Overview
Performance
Key Stats
Geographical Segment: Africa
Performance
Geographical Segment: Asia (excluding Malaysia) and Australia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Malaysia
Performance
Bumi Armada Bhd – Corporate Strategy
Bumi Armada Bhd – SWOT Analysis
SWOT Analysis – Overview
Bumi Armada Bhd – Strengths
Bumi Armada Bhd – Weaknesses
Bumi Armada Bhd – Opportunities
Bumi Armada Bhd – Threats
Bumi Armada Bhd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Oil & Gas Financial Deals and Alliances
Bumi Armada Bhd, Oil & Gas, Deals By Year, 2013 to YTD 2019
Bumi Armada Bhd, Oil & Gas, Deals By Type, 2013 to YTD 2019
Bumi Armada Bhd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 22, 2019: Bumi Armada reports net profit of RM153 million boosted by one off gains in third quarter of 2019
Oct 16, 2019: Bumi Armada announces change of address
Oct 11, 2019: Armada Floating Gas Storage Malta enters into 6-year term loan facility of USD45 million from Mezzanine Equities
Aug 30, 2019: Bumi Armada announces quarterly report on consolidated results for financial period ended 30/06/2019
May 27, 2019: Bumi Armada announces quarterly rpt on consolidated results for financial period ended 31 Mar 2019
May 27, 2019: Bumi Armada announces trading halt and resumption of trading
May 24, 2019: Bumi Armada incorporated new subsidiary
May 23, 2019: EnQuest announces operations update
May 06, 2019: Bumi Armada Bags Third FPSo Project in India
Apr 23, 2019: Bumi Armada: Term loan facilities of USD660 Million
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bumi Armada Bhd, Key Facts
Bumi Armada Bhd, Key Employees
Bumi Armada Bhd, Key Employee Biographies
Bumi Armada Bhd, Major Products and Services
Bumi Armada Bhd, History
Bumi Armada Bhd, Subsidiaries
Bumi Armada Bhd, Joint Venture
Bumi Armada Bhd, Key Competitors
Bumi Armada Bhd, Ratios based on current share price
Bumi Armada Bhd, Annual Ratios
Bumi Armada Bhd, Annual Ratios (Cont...1)
Bumi Armada Bhd, Annual Ratios (Cont...2)
Bumi Armada Bhd, Interim Ratios
Bumi Armada Bhd, Oil & Gas, Deals By Year, 2013 to YTD 2019
Bumi Armada Bhd, Oil & Gas, Deals By Type, 2013 to YTD 2019
Bumi Armada Bhd, Recent Deals Summary
Currency Codes
Units
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Bumi Armada Bhd, Performance Chart (2014 - 2018)
Bumi Armada Bhd, Ratio Charts
Bumi Armada Bhd, Oil & Gas, Deals By Year, 2013 to YTD 2019
Bumi Armada Bhd, Oil & Gas, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Bumi Armada Bhd (ARMADA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fuji Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Palred Technologies Limited:戦略・SWOT・企業財務分析
    Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops vaccines and immunotherapies for cancer and infectious disease. The company uses versamune technology that is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothera …
  • Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Milliken & Co:企業の戦略的SWOT分析
    Milliken & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Shoppers Drug Mart Corporation:企業の戦略・SWOT・財務情報
    Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report Summary Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Banque Cantonale Vaudoise (Private Banking):企業の戦略・SWOT・財務情報
    Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Swedish Orphan Biovitrum AB (SOBI):製薬・医療:M&Aディール及び事業提携情報
    Summary Swedish Orphan Biovitrum AB (Sobi), formerly Biovitrum AB, is an integrated biopharmaceutical company that focuses on the development of products for the treatment of rare diseases. The company specializes in biotechnology with prime capabilities in protein biochemistry and biologics manufac …
  • PT Mitra Adiperkasa Tbk:企業の戦略・SWOT・財務情報
    PT Mitra Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Mitra Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sidney Kimmel Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Sidney Kimmel Comprehensive Cancer Center (Sidney Kimmel) is a healthcare service provider that concentrates on diagnosis, treatment, and prevention of cancer. The center’s specialties include cancer diagnostic and treatment planning, blood and bone marrow cancers, cancer immunotherapy, brai …
  • Eurofarma Laboratorios SA-製薬・医療分野:企業M&A・提携分析
    Summary Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products which include aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoru …
  • Mindray Medical International Ltd-医療機器分野:企業M&A・提携分析
    Summary Mindray Medical International Ltd (Mindray) is a medical device company. Its major products include multi-parameter patient monitors, telemetry monitoring system, defibrillator, anesthesia machine, surgical lights, ceiling supply units, veterinary monitoring systems, hematology analyzer and …
  • HORNBACH-Baumarkt-AG (HBM):企業の財務・戦略的SWOT分析
    HORNBACH-Baumarkt-AG (HBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • University of Wisconsin Madison:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, busines …
  • Interpace Diagnostics Group Inc (IDXG)-製薬・医療分野:企業M&A・提携分析
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; a …
  • Armour Residential REIT, Inc.:企業のM&A・事業提携・投資動向
    Armour Residential REIT, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Armour Residential REIT, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Seegene Inc (096530):企業の財務・戦略的SWOT分析
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務情報
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Actividades de Construccion y Servicios SA:戦略・SWOT・企業財務分析
    Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report Summary Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆